> Investors > 2016 News Releases

2016 News Releases

Keyword Search
 
Category
Year   
DateTitle 
07/18/16ACETO Names Walter Kaczmarek III Chief Operating Officer
PORT WASHINGTON, N.Y., July 18, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), a global leader in the marketing, sale and distribution of  products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that it has named Walter J. Kaczmarek III  its Chief Operating Officer effective August 1, 2016.  Mr. Kaczmarek will assume responsibility for managing day-to-day operations at ACETO’s three business segments, reporting to Salvatore Guccione, Chief... 
Printer Friendly Version
05/23/16ACETO to Present in June Conferences
PORT WASHINGTON, N.Y., May 23, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced it will participate in two investor conferences taking place in June. 13th Annual Craig-Hallum Institutional Investor Conference in Minneapolis, MN on June 1.  Salvatore Guccione, President and CEO will host one-on-one meetings throu... 
Printer Friendly Version
05/05/16ACETO Reports Fiscal 2016 Third Quarter Results
PORT WASHINGTON, N.Y., May 05, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the third quarter of fiscal 2016 ended March 31, 2016. Third Quarter Fiscal 2016 versus Third Quarter Fiscal 2015 Net sales of $157.9 million versus $145.8 million, an 8.3% increase Gross profit of $38.3 mil... 
Printer Friendly Version
05/05/16ACETO Board of Directors Declares Quarterly Cash Dividend
PORT WASHINGTON, N.Y., May 05, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.06 per common share.  This quarterly cash dividend will be distributed on June 24, 2016 to shareholders of record as of June 9, 2016. ABOUT ACETO ACETO Corporat... 
Printer Friendly Version
04/21/16ACETO Corporation Schedules Third Quarter & Fiscal 2016 Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y., April 21, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the third quarter of fiscal 2016 ended March 31, 2016 after the stock market close on Thursday, May 5, 2016. Management will host a conference call to discuss the operating and financial results at 9... 
Printer Friendly Version
04/07/16ACETO to Present at the Needham & Company Healthcare Conference
PORT WASHINGTON, N.Y., April 07, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Salvatore Guccione, President and CEO, will present at the Needham & Company Healthcare Conference on April 12, 2016 at 5:00 pm ET at the Westin New York Grand Central Hotel. A webcast of the presentation will be available und... 
Printer Friendly Version
03/23/16ACETO Subsidiary, Rising Pharmaceuticals, to Launch Lithium Carbonate Extended-release Tablets and Metronidazole Tablets
PORT WASHINGTON, N.Y., March 23, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, is launching Lithium Carbonate Extended-release Tablets, 300mg, an FDA approved generic version of ANI Pharmaceutical Inc.’s Lithobid®, and Metronidazole Tab... 
Printer Friendly Version
02/04/16ACETO Reports Fiscal 2016 Second Quarter Results
PORT WASHINGTON, N.Y., Feb. 04, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the second quarter of fiscal 2016 ended December 31, 2015. Second Quarter Fiscal 2016 versus Second Quarter Fiscal 2015 Net sales of $131.7 million versus $123.8 million, a 6.4% increase Gross profit of $35... 
Printer Friendly Version
02/04/16ACETO Board of Directors Declares Quarterly Cash Dividend
PORT WASHINGTON, N.Y., Feb. 04, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.06 per common share.  This quarterly cash dividend will be distributed on March 25, 2016 to shareholders of record as of March 11, 2016. ABOUT ACETO ACETO Corp... 
Printer Friendly Version
01/27/16ACETO Corporation Schedules Second Quarter & Fiscal 2016 Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y., Jan. 27, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the second quarter of fiscal 2016 ended December 31, 2015 after the stock market close on Thursday, February 4, 2016. Management will host a conference call to discuss the operating and financial resu... 
Printer Friendly Version
01/25/16ACETO Subsidiary, Rising Pharmaceuticals, to Launch Zolmitriptan Tablets
PORT WASHINGTON, N.Y., Jan. 25, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, is launching Zolmitriptan Tablets, 2.5mg and 5mg, an FDA approved generic version of IPR Pharmaceuticals, Inc.’s Zomig®.   According to IMS Health data, U.... 
Printer Friendly Version

top